ANI Pharmaceuticals, Inc. (ANIP)
72.18
-0.78
(-1.07%)
USD |
NASDAQ |
Oct 02, 16:00
72.23
+0.05
(+0.07%)
After-Hours: 20:00
ANI Pharmaceuticals Profit Margin (Quarterly) : 8.65% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.65% |
| March 31, 2026 | 11.55% |
| December 31, 2025 | 10.28% |
| September 30, 2025 | 10.59% |
| June 30, 2025 | 3.66% |
| March 31, 2025 | 7.16% |
| December 31, 2024 | -5.39% |
| September 30, 2024 | -16.29% |
| June 30, 2024 | -1.66% |
| March 31, 2024 | 11.93% |
| December 31, 2023 | 0.88% |
| September 30, 2023 | 7.54% |
| June 30, 2023 | 5.36% |
| March 31, 2023 | 1.35% |
| December 31, 2022 | -4.50% |
| September 30, 2022 | -10.26% |
| June 30, 2022 | -20.21% |
| March 31, 2022 | -31.22% |
| December 31, 2021 | -39.61% |
| September 30, 2021 | -8.54% |
| June 30, 2021 | -29.01% |
| March 31, 2021 | 0.16% |
| December 31, 2020 | -6.35% |
| September 30, 2020 | 0.80% |
| June 30, 2020 | -25.45% |
| Date | Value |
|---|---|
| March 31, 2020 | -14.09% |
| December 31, 2019 | -9.92% |
| September 30, 2019 | 7.46% |
| June 30, 2019 | 11.92% |
| March 31, 2019 | 0.83% |
| December 31, 2018 | 9.41% |
| September 30, 2018 | 9.83% |
| June 30, 2018 | 5.82% |
| March 31, 2018 | 4.81% |
| December 31, 2017 | -20.23% |
| September 30, 2017 | 9.73% |
| June 30, 2017 | 5.94% |
| March 31, 2017 | 3.12% |
| December 31, 2016 | -2.79% |
| September 30, 2016 | 6.56% |
| June 30, 2016 | 3.56% |
| March 31, 2016 | 6.51% |
| December 31, 2015 | 15.93% |
| September 30, 2015 | 22.68% |
| June 30, 2015 | 18.17% |
| March 31, 2015 | 23.12% |
| December 31, 2014 | 99.56% |
| September 30, 2014 | 38.31% |
| June 30, 2014 | -35.55% |
| March 31, 2014 | 30.51% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -584.5% |
| Liquidia Corp. | 43.52% |
| Elanco Animal Health, Inc. | 3.95% |
| Harmony Biosciences Holdings, Inc. | 28.87% |
| Corcept Therapeutics, Inc. | 16.45% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 18.91% |
| Return on Assets | 7.03% |
| Return on Invested Capital | 8.66% |
| Gross Profit Margin (Quarterly) | 54.97% |
| Operating Margin (Quarterly) | 14.97% |
| Return on Net Operating Assets | 9.10% |